2022
DOI: 10.1007/s12471-022-01688-6
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of prognosis in patients with left ventricular dysfunction using three-dimensional strain echocardiography and cardiac magnetic resonance imaging

Abstract: Background We evaluated three-dimensional speckle tracking echocardiography (3DSTE) strain and cardiac magnetic resonance (CMR) with delayed contrast enhancement (DCE) for the prediction of cardiac events in left ventricular (LV) dysfunction. Methods CMR and 3DSTE in 75 patients with ischaemic and 38 with non-ischaemic LV dysfunction were analysed and temporally correlated to cardiac events during 41 ± 9 months of follow-up. Resu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 31 publications
0
2
0
1
Order By: Relevance
“…41 However, a recent study of patients with ischemic and non-ischemic cardiomyopathy did not find an incremental value for 3D strain in comparison with analysis of LVEF. 46…”
Section: Barros-filho and Romano 3d Echocardiography In Chagas Diseasementioning
confidence: 99%
“…41 However, a recent study of patients with ischemic and non-ischemic cardiomyopathy did not find an incremental value for 3D strain in comparison with analysis of LVEF. 46…”
Section: Barros-filho and Romano 3d Echocardiography In Chagas Diseasementioning
confidence: 99%
“…41 Porém, em estudo recente em pacientes com miocardiopatia isquêmica e não isquêmica não foi encontrado valor incremental da deformação 3D em comparação com a análise da FEVE. 46…”
Section: Barros-filho and Romano Ecocardiograma 3d Na Doença De Chagasunclassified
“…This area aims at producing surrogate biomarkers to reduce cost or invasivity, e.g., neuroimaging to replace lumbar puncture. Prediction of clinical measures, e.g., ADAS-Cog13 [75] and ventricular volume [76], is also used for longitudinal studies and attempts to achieve a more comprehensive evaluation of disease progression and model performance benchmarking.…”
mentioning
confidence: 99%